Sundrug Co.,Ltd.

TSE:9989.T

4083 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 751,777690,462648,734634,310617,769588,069564,215528,394503,773445,818447,819407,401386,836360,655284,112232,532218,133197,768177,507153,949
Cost of Revenue 562,457518,516492,228475,760463,150440,891423,256397,646379,654337,582341,974310,870296,947278,858218,312177,747167,803152,227137,746120,042
Gross Profit 189,320171,946156,506158,550154,619147,178140,959130,748124,119108,236105,84596,53189,88981,79765,80054,78550,33045,54139,76133,907
Gross Profit Ratio 0.2520.2490.2410.250.250.250.250.2470.2460.2430.2360.2370.2320.2270.2320.2360.2310.230.2240.22
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 11000000000003181844091793039911
Selling & Marketing Expenses 148,3120000000000000000000
SG&A 148,323134,495122,454120,879117,996111,671104,62096,50790,86882,16877,50071,5823181844091793039911
Other Expenses 635594530660426436582678651453600464456510426175153155171215
Operating Expenses 148,323134,491122,454121,201118,011111,941104,87596,69091,09182,30977,78571,80739,85237,34629,28523,45721,48932,78727,41022,844
Operating Income 40,99737,45234,05237,34536,60435,23336,08034,05533,02525,92428,05724,72022,26319,23216,02014,84113,98912,75012,34711,059
Operating Income Ratio 0.0550.0540.0520.0590.0590.060.0640.0640.0660.0580.0630.0610.0580.0530.0560.0640.0640.0640.070.072
Total Other Income Expenses Net 264259622-158-1,958-164514366250643-881304-27,581-25,584-20,210-16,472-15,4492363188
Income Before Tax 41,26137,71034,67537,18834,64835,07136,59834,42433,27726,56927,17825,02822,45618,86716,30514,85613,39212,77712,41411,251
Income Before Tax Ratio 0.0550.0550.0530.0590.0560.060.0650.0650.0660.060.0610.0610.0580.0520.0570.0640.0610.0650.070.073
Income Tax Expense 12,13412,00710,82111,85910,95611,13711,76811,11211,70810,20711,42410,0729,8757,9966,8655,9375,6855,2855,0954,626
Net Income 29,12625,70323,85325,32923,69223,93324,82923,31221,56916,36215,75414,95512,58010,8719,4408,9187,7067,4927,3196,625
Net Income Ratio 0.0390.0370.0370.040.0380.0410.0440.0440.0430.0370.0350.0370.0330.030.0330.0380.0350.0380.0410.043
EPS 249.06219.83204.02216.67202.67204.75212.31197.32178.43133.49124.99118.6599.8186.2574.970.7661.1159.31114.59103.18
EPS Diluted 249.06219.81204.01216.63202.66204.75212.31197.31178.43133.48124.99118.6599.8186.2574.970.7661.1159.31114.59103.18
EBITDA 56,23950,23944,91746,80145,52644,04844,58741,85040,24232,73434,39730,61155,50849,24940,18734,04631,33114,94314,28612,695
EBITDA Ratio 0.0750.0730.0690.0740.0740.0750.0790.0790.080.0730.0770.0750.1430.1370.1410.1460.1440.0760.080.082